Metal artifact reduction for 3 T MRI-only prostate radiotherapy in patients with hip prostheses: impact on target definition, synthetic CT generation, dose calculation, and fiducial marker identification.

Coskun M, Petersson JS, Wetterstedt SA, Brynolfsson P, Gustafsson CJ, Gunnlaugsson A, Olsson LE, Siversson C

Open source

DOI
10.1186/s13014-026-02922-w
Published
2026 Sep 7
Container
Radiation oncology (London, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13014-026-02922-w,
  title = {Metal artifact reduction for 3 T MRI-only prostate radiotherapy in patients with hip prostheses: impact on target definition, synthetic CT generation, dose calculation, and fiducial marker identification.},
  author = {Coskun M and Petersson JS and Wetterstedt SA and Brynolfsson P and Gustafsson CJ and Gunnlaugsson A and Olsson LE and Siversson C},
  year = {2026},
  journal = {Radiation oncology (London, England)},
  doi = {10.1186/s13014-026-02922-w},
  url = {https://doi.org/10.1186/s13014-026-02922-w}
}

RIS

TY  - JOUR
TI  - Metal artifact reduction for 3 T MRI-only prostate radiotherapy in patients with hip prostheses: impact on target definition, synthetic CT generation, dose calculation, and fiducial marker identification.
AU  - Coskun M
AU  - Petersson JS
AU  - Wetterstedt SA
AU  - Brynolfsson P
AU  - Gustafsson CJ
AU  - Gunnlaugsson A
AU  - Olsson LE
AU  - Siversson C
PY  - 2026
JO  - Radiation oncology (London, England)
DO  - 10.1186/s13014-026-02922-w
UR  - https://doi.org/10.1186/s13014-026-02922-w
ER  - 

APA

M, C., JS, P., SA, W., P, B., CJ, G., A, G., LE, O., & C, S. (2026). Metal artifact reduction for 3 T MRI-only prostate radiotherapy in patients with hip prostheses: impact on target definition, synthetic CT generation, dose calculation, and fiducial marker identification.. Radiation oncology (London, England). https://doi.org/10.1186/s13014-026-02922-w

Source records